Choksi Laboratories Share Price
Small Cap | Pharmaceuticals and health care | BSE: 526546
₹113.00 -5.90 (-4.96 %)
Last Updated: 07 Apr 2025 04:01 PM
Overview
Open (₹) 113.00
High (₹) 113.00
Low (₹) 113.00
Prev. Close (₹) 118.90
Volume 1,622
VWAP (₹) 119.35
ROCE (%) 10.83
Industry P/E 59.42
TTM P/E 61.41
P/B Ratio 3.54
Market Cap (₹) Cr.78.71
Dividend Yield (%)--
EPS (₹) 1.59
ROE4.99%
Sales Growth (%) 6.55
Profit Growth (%)-65.43
Day Range
113.00113.00
52 Week Range
48.25142.40
Historical Returns
Returns (6M)
62.29 %
Returns (1Y)
112.01 %
Returns (3Y)
314.68 %
Returns (5Y)
1173.96 %
Returns (6M)
62.29 %
Returns (1Y)
112.01 %
Returns (3Y)
314.68 %
Returns (5Y)
1173.96 %
SWOT Analysis
- Growth in Net Profit Margin (QoQ)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 48.22
MFI 64.78
ATR 3.21
Commodity Channel Index -204.18
ROC125 55.48
ROC21 -4.60
Williams %R -100.00
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 119.70 | 120.30 | 120.60 | 119.40 | 118.80 | 118.50 | 117.90 |
Week Ago | 130.70 | 132.40 | 133.30 | 129.80 | 128.10 | 127.20 | 125.50 |
Month Ago | 118.90 | 121.56 | 125.01 | 115.45 | 112.79 | 109.34 | 106.68 |
EMA & SMA
113.00
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
14
5 Day 125.67
9 Day 129.08
10 Day 130.13
12 Day 131.87
14 Day 131.79
20 Day 133.22
26 Day 128.31
50 Day 110.90
100 Day 88.56
200 Day 77.25
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
PARDEEP KUMAR AGGARWAL HUF | bulk | Sell | 18 Mar, 2025 | ₹129.96 | 1,02,201 | BSE |
SANJAY AGARWAL | bulk | Buy | 18 Mar, 2025 | ₹129.95 | 40,000 | BSE |
PARDEEP KUMAR AGGARWAL HUF | bulk | Buy | 18 Mar, 2025 | ₹125.00 | 15 | BSE |
ANITA AGARWAL | bulk | Buy | 18 Mar, 2025 | ₹129.94 | 40,000 | BSE |
NEXUS GLOBAL OPPORTUNITIES FUND | bulk | Buy | 27 Feb, 2025 | ₹121.50 | 35,000 | BSE |
EMKAY COMMERCIAL COMPANY LIMITED | bulk | Buy | 18 Feb, 2025 | ₹132.65 | 69,000 | BSE |
ASC CONSULTING PRIVATE LIMITED | bulk | Buy | 18 Feb, 2025 | ₹132.51 | 62,000 | BSE |
DHEERAJ KUMAR LOHIA | bulk | Sell | 11 Feb, 2025 | ₹136.85 | 41,222 | BSE |
EMKAY COMMERCIAL COMPANY LIMITED | bulk | Buy | 11 Feb, 2025 | ₹137.17 | 91,000 | BSE |
CSG FINANCIAL & MANAGEMENT SERVICES PRIVATE LIMITED | bulk | Sell | 27 Jan, 2025 | ₹110.58 | 42,583 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
07 Apr, 2025 | BSE India | Pursuant to Regulation 74(5) of SEBI (DP) Regulation, 2018 attached herewith the certificate issued by RTA of the company |
14 Feb, 2025 | BSE India | Integrated Financials for the quarter and nine month ended 31st December, 2024 |
14 Feb, 2025 | BSE India | Considered and approved unaudited financial results for the quarter and nine month ended 31st December, 2025 |
14 Feb, 2025 | BSE India | 1. Considered and approved Unaudited Financial Results for the Quarter and Nine Month ended 31st December, 2024 along with the Limited review report;\r\n2. Other routine businesses with the permission of Chair\r\n |
05 Feb, 2025 | BSE India | CHOKSI LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as nine months ended on 31st December, 2024 along with the Limited Review Report thereon;\r\n2. Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any. |
07 Jan, 2025 | BSE India | Pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 attached herewith the certificate issued by RTA of the company for the quarter ended 31.12.2024 |
03 Jan, 2025 | BSE India | Intimation regarding change in name of RTA of the company is attached herewith |
03 Jan, 2025 | BSE India | The clarification is attached herewith |
03 Jan, 2025 | BSE India | The Exchange has sought clarification from Choksi Laboratories Ltd on January 3, 2025, with reference to Movement in Price.<BR><BR>The reply is awaited. |
14 Nov, 2024 | BSE India | Considered and approved Unaudited Financial Results along with Limited review report for the quarter and half year ended 30th September,2024 |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 06 Feb, 2025 | 14 Feb, 2025 |
Quarterly Results | -- | 06 Nov, 2024 | 14 Nov, 2024 |
Quarterly Results | -- | 06 Aug, 2024 | 13 Aug, 2024 |
Audited Results | -- | 22 May, 2024 | 29 May, 2024 |
Others | To consider, reviews and finalize the matters to be included in the Postal Ballot Notice, E-voting period and other matters pursuant to which. | 23 Mar, 2024 | 27 Mar, 2024 |
Quarterly Results | -- | 30 Jan, 2024 | 03 Feb, 2024 |
Quarterly Results | -- | 06 Nov, 2023 | 10 Nov, 2023 |
Quarterly Results & A.G.M. | -- | 07 Aug, 2023 | 12 Aug, 2023 |
Others | -- | 04 Jul, 2023 | 05 Jul, 2023 |
Audited Results | -- | 24 May, 2023 | 29 May, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% |
Foreign Institutions + | 0% | 0% | 0% | 0% | 0% |
Domestic Institutions + | 0% | 0% | 0% | 0% | 0% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 68.52% | 68.52% | 68.52% | 68.52% | 68.52% |
Others | 0% | 0% | 0% | 0% | 0% |
About Choksi Laboratories
Choksi Laboratories is a Public Limited Listed company incorporated on 29/01/1993 and has its registered office in the State of Madhya Pradesh, India. Company’s Corporate Identification Number(CIN) is L85195MP1993PLC007471 and registration number is 007471. Currently company belongs to the Industry of Medical Research Services. Company’s Total Operating Revenue is Rs. 36.70 Cr. and Equity Capital is Rs. 6.97 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1993
Managing Director
Mr. Sunil Kumar Choksi
NSE Symbol
--
Choksi Laboratories Management
Name | Designation |
---|---|
Mr. Sunil Kumar Choksi | Managing Director |
Mrs. Stela Choksi | Whole Time Director |
Ms. Himika Choksi | Whole Time Director |
Mr. Vyangesh Choksi | Whole Time Director |
Mr. Raghmendra Singh | Independent Director |
Mrs. Meenaxi Patidar | Independent Director |
Mrs. Prachi Mantri | Independent Director |
Mrs. Abha Shastri | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Syngene International | ₹28,060.85 | ₹697.10 ₹724.65(-3.80%) | ₹608.000 - ₹960.000 |
Sun Pharma Advanced Research Company | ₹4,627.03 | ₹142.58 ₹145.54(-2.03%) | ₹109.200 - ₹474.000 |
Suven Life Sciences | ₹2,590.93 | ₹118.81 ₹128.72(-7.70%) | ₹83.270 - ₹169.000 |
Vimta Labs | ₹1,923.40 | ₹865.05 ₹924.45(-6.43%) | ₹420.000 - ₹1,183.000 |
Choksi Laboratories | ₹78.71 | ₹113.00 ₹118.90(-4.96%) | ₹46.510 - ₹142.400 |
FAQs on Choksi Laboratories
What is the share price of Choksi Laboratories?
The share price of Choksi Laboratories on 07 Apr, 2025 is ₹ 113.00.
What is 52W high and 52W low share price of Choksi Laboratories?
The highest and lowest 52W share prices of Choksi Laboratories are ₹ 142.400 and ₹ 46.510
What is the market cap of Choksi Laboratories?
The market capitalization of Choksi Laboratories as of 07 Apr, 2025 is ₹ 78.71 Crores
What is the P/E ratio of Choksi Laboratories?
The current P/E ratio of Choksi Laboratories as of 07 Apr, 2025 is 59.42
What is the PB ratio of Choksi Laboratories?
The PB ratio of Choksi Laboratories as of 07 Apr, 2025 is 3.54
Top Gainers
₹67.00
₹56.11 (0.19%)
₹64.50
₹55.00 (0.17%)
₹30.18
₹25.15 (0.20%)
₹33.41
₹27.96 (0.19%)
Top Losers
₹20.60
₹24.76 (-0.17%)
₹6.40
₹7.52 (-0.15%)
₹2,814.65
₹4,939.80 (-0.43%)
₹75.12
₹89.69 (-0.16%)
Market Indices
Sensex
₹73,137.90
₹75,364.69 (-0.03%)